Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Baricitinib improved hair loss and arthritis in a lupus patient.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

Platelet-rich plasma mesotherapy improved symptoms in patients with corticosteroid-induced rosacea-like dermatitis.

The drug combination was safe and showed promise in treating advanced tumors.